Radiation‐associated breast cancers in a late‐effects cohort: Long‐term surveillance is essential
- 7 September 2020
- journal article
- research article
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 16 (6) , 363-371
Abstract
Aims: Survivors of childhood, adolescent, and young adulthood malignancies have an increased risk of subsequent primary malignancies, particularly after exposure to therapeutic radiation. This study aims to evaluate the mode of surveillance and surveillance compliance, incidence and mode of detection of breast cancer, breast cancer phenotype, and outcomes after radiation‐associated breast cancer (RBC) in a late‐effects cohort.Methods: Women exposed to therapeutic radiation attending the late effects service from 1st January 2000 to 20th February 2013. All invasive and in‐situ cancers, benign tumors, and deaths were evaluated. The incidence of breast cancer was compared to the Australian general population. Compliance with breast surveillance recommendations, clinicopathological features, and management of breast cancers were examined.Results: The prevalence of RBC was 17.1%. Twenty‐eight cases of RBC occurred in 24 women, out of 140 women exposed to chest radiation. Patients whose first attendance was ≥15 years after radiation exposure experienced the highest incidence of RBC at 23%. The incidence of breast cancer was 11.2 times the general population (P < .001). Compliance with surveillance mammography was observed in 18.4%. Breast cancers diagnosed after the first attendance to the service were more likely screen‐detected (P = .002). Most were hormone receptor positive (84.0%), invasive ductal carcinomas (82.1%), and managed with mastectomy (89.3%).Conclusions: Patients attending a dedicated late effects service have a high burden of subsequent malignancies generally occurring after long latency. Judicious management with adherence to long‐term surveillance guidelines is advocated.Keywords
This publication has 44 references indexed in Scilit:
- MRI screening for breast cancer in women at high risk; is the Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer?Journal of Medical Radiation Sciences, 2015
- Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization GroupThe Lancet Oncology, 2013
- Risk of second breast cancer in female Hodgkin’s lymphoma survivors: a meta-analysisBMC Cancer, 2012
- Subsequent Malignancies in Children Treated for Hodgkin's Disease: Associations With Gender and Radiation DoseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- The Late Effects Clinic in action: For survivors of childhood malignancyActa Oncologica, 2007
- High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screeningBritish Journal of Cancer, 2006
- The involved field is back: issues in delineating the radiation field in Hodgkin's diseaseAnnals of Oncology, 2002
- Second Cancers Among Long-Term Survivors of Hodgkin’s Disease Diagnosed in Childhood and AdolescenceJournal of Clinical Oncology, 2000
- Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's DiseaseNew England Journal of Medicine, 1996